申请人:Chapdelaine Marc
公开号:US20060019947A1
公开(公告)日:2006-01-26
Provided herein is a compound of the formula (I) wherein said compound is useful for the treatment of psychiatric disorders including but not limited to depression, generalized anxiety, eating, disorders, dementia, panic disorder, and sleep disorders. The compounds may also be useful in the treatment of gastrointestinal disorders, cardiovascular regulation, motor disorders, endocrine disorders, vasospasm and sexual dysfunction. The compounds are 5HT
1B
in antagonists. Also provided herein are processes for making compounds of Formula (I) and intermediate compounds.
本文提供了一种化合物,其化学式为(I),其中该化合物可用于治疗精神障碍,包括但不限于抑郁症、广泛性焦虑、进食障碍、痴呆症、惊恐障碍和睡眠障碍。该化合物也可用于治疗胃肠道障碍、心血管调节、运动障碍、内分泌障碍、血管痉挛和性功能障碍。该化合物是5HT1B受体拮抗剂。本文还提供了制备化合物I及其中间体化合物的方法。